Please login first

1st International Electronic Conference on Biomedicine

01/03/2021 - 26/03/2021
Abstract Submission
30th November 2020
Acceptance Notification
14th December 2020
Full Paper Submission
25th January 2021

Therapeutic Targets, Therapeutic Strategies, Naturally Driven Biomedicines, Pharmaceuticals, Biopharmaceutical Products
Add this conference to bookmark
Submit Abstract Contact Us

Welcome from the Chairs

Dear Colleagues,

It is my pleasure to invite you to join the 1st International Electronic Conference on Biomedicine (ECB 2021) that is hosted online by: https://ecb2021.sciforum.net.

ECB 2021 will present the latest research related to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products.

Topics of interest include but are not limited to:

  1. Nanomedicine and Precision Medicine
  2. Nutraceuticals, Nano Nutraceuticals and Nano Pharmaceuticals
  3. Cancer Therapeutics
  4. Metal-based Therapeutics in Preclinical and Clinical Developments
  5. Oncolytic Virus-mediated Immunotherapy
  6. Neuroprotective Therapies in Spinal Cord Injury; the First and Necessary Step Towards the Cure
  7. Exploring Biomedicines in Behavioral Neurology and Neuropsychiatry
  8. Nanomaterials and Its Application in Biomedicine, including Drug/Gene/Vaccine Delivery, Imaging, Medical Devices and Surgical Implants
  9. Translational Biomarkers in Clinical Biomedicine and Precision Medicine
  10. G-protein-coupled Receptor Family
  11. Microbiota, Probiotics and Nutraceuticals: Preventive and Therapeutic Potential

ECB 2021 seeks to fulfill this need by offering a completely digital (online) method for running a scientific conference. ECB 2021 will allow its participants to share their latest research results and receive near-instantaneous feedback from biomedical researchers throughout the world through online question and answer sessions and discussion groups. In this way, ECB 2021 will serve as a platform for advancing the state-of-the-art in biomedicines. There is no cost to participate in ECB 2021.

All submitted abstracts will be evaluated by the conference committee. Upon acceptance of their abstract, authors will contribute an extended abstract for the conference proceedings and a slide presentation of their work. The authors of the most outstanding contributions will be invited to submit a full manuscript for potential publication in Biomedicines (https://www.mdpi.com/journal/biomedicines).

I hope you will choose to be a part of this exciting conference and present your most transformative research on biomedicine.

Conference Secretariat

Ms. Nicole Peng
MDPI Branch Office, Wuhan
E-mail: [email protected]

Ms. Penny Zhang
MDPI Branch Office, Wuhan
E-mail: [email protected]

Call for Papers

The 1st International Electronic Conference on Biomedicine will be held on 1-26 March 2021. ECB 2021 aims to promote and advance the exciting and rapidly changing field of Biomedicine. All proceedings will be held online at https://ecb2021.sciforum.net.

Topics of interest include, but are not limited to:

  1. Nanomedicine and Precision Medicine
  2. Nutraceuticals, Nano Nutraceuticals and Nano Pharmaceuticals
  3. Cancer Therapeutics
  4. Metal-based Therapeutics in Preclinical and Clinical Developments
  5. Oncolytic Virus-mediated Immunotherapy
  6. Neuroprotective Therapies in Spinal Cord Injury; the First and Necessary Step Towards the Cure
  7. Exploring Biomedicines in Behavioral Neurology and Neuropsychiatry
  8. Nanomaterials and Its Application in Biomedicine, including Drug/Gene/Vaccine Delivery, Imaging, Medical Devices and Surgical Implants
  9. Translational Biomarkers in Clinical Biomedicine and Precision Medicine
  10. G-protein-coupled Receptor Family
  11. Microbiota, Probiotics and Nutraceuticals: Preventive and Therapeutic Potential

ECB 2021 is an electronic conference sponsored by Biomedicines. Participation is free of charge for authors and attendees. Accepted papers will be gathered in the proceedings of the conference. Selected extended versions of the papers will be published in a Special Issue of Biomedicines and undergo full peer review (ISSN 2227-9059; impact factor: 4.717 (2020)) with a 20% discount on the article processing charge. ECB 2021 offers you the opportunity to participate in this international, scholarly conference without the concerns or expenditure of travel—all you need is your computer and access to the internet. We would like to invite you to attend this conference and present your latest work.

Abstracts (in English) should be submitted online by 30 November 2020 at https://ecb2021.sciforum.net. For accepted abstracts, the proceedings can be submitted by 25 January 2021. The conference will be held on 1-26 March 2021.

Paper Submission Guidelines

For information about the submission procedure and preparation of a full presentation, please refer to the "Instructions for Authors".

Time Schedule
  • Abstract Submission: 30 November 2020
  • Notification of Acceptance: 14 December 2020
  • Paper Submission Deadline: 25 January 2021
  • Conference Open: 1-26 March 2021

We thank you in advance for your attendance of this conference and look forward to a stimulating exchange.



Conference Chairs

Professor Shaker A. Mousa

Albany College of Pharmacy and Health Sciences, Rensselaer, USA

Dr. Veronique Baud

Faculté de Pharmacie, Paris, France

Session Chairs

Prof. Shaker A. Mousa

Albany College of Pharmacy and Health Sciences, Rensselaer, USA

DETAILS

Nanomedicine and Precision Medicine; Nutraceuticals, Nano Nutraceuticals and Nano Pharmaceuticals

Section topic
Nanomedicine and Precision Medicine; Nutraceuticals, Nano Nutraceuticals and Nano Pharmaceuticals

Veronique Baud

Faculté de Pharmacie, Paris, France

DETAILS

Cancer Therapeutics

Section topic
Cancer Therapeutics

Muhammad Hanif

The University of Auckland, Auckland, New Zealand

DETAILS

Metal-based Therapeutics in Preclinical and Clinical Developments

Section topic
Metal-based Therapeutics in Preclinical and Clinical Developments

Zong Sheng Guo

The University of Pittsburgh Cancer Institute, and University of Pittsburgh School of Medicine, Pittsburgh, USA

DETAILS

Oncolytic Virus-Mediated Immunotherapy

Section topic
Oncolytic Virus-Mediated Immunotherapy

Jacek M. Kwiecien

McMaster University, Ontario, Canada

DETAILS

Neuroprotective Therapies in Spinal Cord Injury; the First and Necessary Step Towards the Cure

Section topic
Neuroprotective Therapies in Spinal Cord Injury; the First and Necessary Step Towards the Cure

Masaru Tanaka

University of Szeged, Szeged, Hungary

DETAILS

Exploring Biomedicines in Behavioral Neurology and Neuropsychiatry

Section topic
Exploring Biomedicines in Behavioral Neurology and Neuropsychiatry

Alexander Seifalian

The London BioScience Innovation Centre, London, United Kingdom

DETAILS

Nanomaterials and Its Application in Biomedicine, including Drug/Gene/Vaccine Delivery, Imaging, Medical Devices and Surgical Implants

Section topic
Nanomaterials and Its Application in Biomedicine, including Drug/Gene/Vaccine Delivery, Imaging, Medical Devices and Surgical Implants

Allan Stensballe

Alborg University, Aalborg, Denmark

DETAILS

Translational Biomarkers in Clinical Biomedicine and Precision Medicine

Section topic
Translational Biomarkers in Clinical Biomedicine and Precision Medicine

Ujendra Kumar

The University of British Columbia, Vancouver, Canada

DETAILS

G-protein-coupled Receptor Family

Section topic
G-protein-coupled Receptor Family

Ciro Isidoro

Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy

DETAILS

Microbiota, Probiotics and Nutraceuticals: Preventive and Therapeutic Potential

Section topic
Microbiota, Probiotics and Nutraceuticals: Preventive and Therapeutic Potential

Instructions for Authors

Instructions for Authors
Submission

Submissions should be submitted by the authors online by registering at https://ecb2021.sciforum.net/, and using the “Submit Abstract” function once logged into system.

  1. Scholars interested in participating with the conference can submit their abstract (about 200–250 words covering the areas of manuscripts for the proceedings issue) online at this website up to 30 November 2020.
  2. The Conference Committee will conduct a pre-evaluation, based on the submitted abstract, of whether the contribution from the authors of the abstract will be welcome for the 1st International Electronic Conference on Biomedicine. All authors will be notified by 14 December 2020 about the acceptance of their abstract.
  3. If the abstract is accepted for this conference, the author is asked to submit the manuscript optionally along with a PowerPoint and/or video presentation of his/her paper (only PDF), up to the submission deadline of 25 January 2021.
  4. The conference proceedings papers and presentations will be available at https://ecb2021.sciforum.net for discussion during the time of the conference, 1-26 March 2021, and will be published in Journal Proceedings.
  5. The open access journal Biomedicines will publish a Special Issue of the conference and accepted papers will be published in the proceedings of the conference itself. After the conference, the Conference Committee will select manuscripts that may be included for publication in the Special Issue of the journal Biomedicines (the submission to the journal is independent from the conference proceedings and will follow the usual process of the journal, including peer-review, APC, etc.).
Proceedings Paper

Manuscripts for the proceedings issue must have the following organization:

First page:

  • Title
  • Full author names
  • Affiliations (including full postal address) and authors’ e-mail addresses
  • Abstract (200–250 words)
  • Keywords
  • Introduction
  • Methods
  • Results and Discussion
  • Conclusions
  • (Acknowledgements)
  • References

Manuscripts should be prepared in MS Word or any other word processor and should be converted to PDF format before submission. The publication format will be PDF. The manuscript should be at least 3 pages (incl. figures, tables, and references) and should not exceed 6 pages.

Presentation Slides

Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the manuscript. Slides, if available, will be displayed directly in the website using the proprietary slides viewer at Sciforum.net. Slides can be prepared in exactly the same way as for any traditional conference where research results can be presented. Slides should be converted to PDF format before submission so that we can easily and automatically process them for online display.

Video Presentations

Besides their active participation within the forum, authors are also encouraged to submit video presentations. The video should be no longer than 20 minutes and be prepared in one of the following formats:

  • MOV
  • MPEG4
  • MP4
  • AVI
  • WMV
  • MPEGPS
  • FLV
Presentation of Posters

Authors that wish to present only a poster, i.e., without a proceedings paper, can do so in section I. Posters will be available on the conference website during and after the event. Similarly to papers presented at the conference, participants will be able to ask questions and make comments about the posters. Posters that are submitted without a paper will not be included in the proceedings of the conference.

Submission of Manuscripts

Submission: Manuscripts should be submitted online at https://ecb2021.sciforum.net by registering and logging in to this website.

Accepted File Formats

  • MS Word: Manuscript prepared in MS Word must be converted into a single file before submission. When preparing manuscripts in MS Word, the 1st International Electronic Conference on Microbiology Microsoft Word template file (see download below) must be used. Please do not insert any graphics (schemes, figures, etc.) into a movable frame which can superimpose the text and make layout very difficult.

1st International Electronic Conference on Biomedicine Microsoft Word template file

ECB_2021_Word_template.docx

Manuscript Preparation

  • Paper Format: A4 paper format, the printing area is 17.5 cm × 26.2 cm. The margins should be 1.75 cm on each side of the paper (top, bottom, left, and right sides).
  • Paper Length: The conference proceedings paper should not be longer than 6 pages. The conference manuscript should be as concise as possible.
  • Formatting/Style: The paper style of the journal Proceedings should be followed. You may download the template file to prepare your paper (see above). The full titles of the cited papers must be given. Reference numbers should be placed in square brackets [ ], and placed before punctuation; for example [4] or [1–3], and all the references should be listed separately and as the last section at the end of the manuscript.
  • Authors List and Affiliation Format: Authors’ full first and last names must be given. Abbreviated middle name(s) can be added. For papers written by various contributors, a corresponding author must be designated. The PubMed/MEDLINE format is used for affiliations: complete street address information including city, zip code, state/province, country, and email address should be added. All authors who contributed significantly to the manuscript (including writing a section) should be listed on the first page of the manuscript, below the title of the article. Other parties who provided only minor contributions should only be listed under Acknowledgments. A minor contribution might be a discussion with the author, reading through the draft of the manuscript, or performing English corrections.
  • Figures, Schemes, and Tables: Authors are encouraged to prepare figures and schemes in color. Full color graphics will be published free of charge. Figure and schemes must be numbered (Figure 1, Scheme I, Figure 2, Scheme II, etc.) and an explanatory title must be added. Tables should be inserted into the main text, and numbers and titles for all tables supplied. All table columns should have an explanatory heading. Please supply legends for all figures, schemes, and tables. The legends should be prepared as a separate paragraph of the main text and placed in the main text before a table, figure, or scheme.

Potential Conflicts of Interest

It is the authors’ responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state here “The authors declare no conflict of interest”. This should be conveyed in a separate “Conflict of Interest” statement preceding the “Acknowledgments” and “References” sections at the end of the manuscript. Financial support for the study must be fully disclosed under the “Acknowledgments” section.

Copyright

MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their scholarly works. Hence, by submitting a Communication paper to this conference, you retain the copyright of your paper, but you grant MDPI the non-exclusive right to publish this paper online on the Sciforum.net platform. This means you can easily submit your paper to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).

Conference Awards

To acknowledge the support of the conference esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to launch the Best Paper Award and Best Poster Award.

The Awards
Best Paper Award 500 CHF
The Best Paper Award is presented to the paper judged to make the most significant contribution to the conference.
Best Poster Award 500 CHF
The Best Poster Award was established to recognize the scientific merit exhibited in poster presentation and preparation.
Terms and Conditions:
Best Paper Award

As a sponsor, Biomedicines would like to award the best paper as elected by the conference committee. The award will consist of 500 Swiss Francs. We look forward to posting your contributions.

Criteria for Evaluation of Best Paper Award:

  • Full paper must be submitted to ECB2021;
  • Originality/novelty of the paper;
  • Significance of content;
  • Scientific soundness;
  • Interest to the readers;
  • English language and style.

Evaluation

  • Each Evaluation Committee member will give an assessment for each applicant in terms of the criteria outlined above;
  • The total score for each presentation will be ranked from highest to lowest;
  • If two or more authors receive the same score, further evaluation will be carried out;
  • All decisions made by the Evaluation Committee are final.
Best Poster Award


As a sponsor, Biomedicines would like to grant an award (500 Swiss Francs) for the best poster presented at the conference. This prize is awarded by a jury to the best designed poster presented at the conference.

Posters should have the following information.

  • Title (with authors and affiliations)
  • Introduction/Objectives/Aims
  • Methods
  • Results
  • Conclusion
  • References
  • Acknowledgements
  • Contact information
  • A 3-minute video presentation

During the conference, the chair is invited to judge the quality of the 3-minute video presentation and poster. Criteria for judgement of the presentation will be the ability to summarize the content of the work and motivate the interest in looking at the poster. In addition, the clarity of poster and appearance quality will be considered.

Sponsors and Partners

Organizers

Top